Fig. 2
From: Hyperlipidemia and mortality in patients on peritoneal dialysis
Associations between hyperlipidemia and all-cause mortality in subgroups over the overall follow-up period (A) and from 48-month follow-up onwards (B)
Adjusted for age, sex, body mass index, systolic BP, diastolic BP, 24-hour urine volume, current smoking, current alcohol consumption, Charlson comorbidity index, diabetes mellitus, hypertension, and a history of CVD, calcium channel blockers, beta-blockers, ACEI/ARBs, diuretics, statins, aspirin, hemoglobin, serum albumin, serum uric acid, eGFR, cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, and hs-CRP.
BP, blood pressure; CVD, cardiovascular disease; ACEI/ARBs, angiotensin II receptor blockers/angiotensin-converting enzyme inhibitors; eGFR, estimated glomerular filtration rate; hs-CRP, high-sensitivity C-reactive protein; HR, hazards ratio; CI, confidence interval